Literature DB >> 16463

The pressor activity of burimamide: a relationship between chemical constitution and pressor activity of burimamide and related histamine H2-receptor antagonists.

C R Ganellin, D A Owen.   

Abstract

Burimamide, a histamine H2-receptor antagonist, has been shown to cause pressor responses in pithed rats. The response can be prevented by prior removal of the adrenal glands or by pretreatment with the alpha-adrenoceptor antagonist, phentolamine, 5 mg/kg, suggesting that the pressor response to burimamide is due to release of catecholamines from the adrenal glands. The pressor activity of burimamide has been compared with that of metiamide and two close chemical analogues, methylburimamide and thiaburimamide, in order to identify which chemical features of the compounds are necessary for this activity. Methylburimamide was the most potent pressor agent, followed by burimamide, metiamide and thiaburimamide. The pressor effects (and presumably catecholamine-releasing activities) appear to be related to the basicities of the compounds. We conclude that the release of catecholamines by these histamine H2-receptor antagonists is probably due to their cationic (imidazolium) forms.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 16463     DOI: 10.1007/BF01964887

Source DB:  PubMed          Journal:  Agents Actions        ISSN: 0065-4299


  7 in total

1.  The pharmacology of burimamide and metiamide, two histamine H2-receptor antagonists.

Authors:  R W Brimblecombe; W A Duncan; D A Owen; M E Parsons
Journal:  Fed Proc       Date:  1976-06

2.  Definition and antagonism of histamine H 2 -receptors.

Authors:  J W Black; W A Duncan; C J Durant; C R Ganellin; E M Parsons
Journal:  Nature       Date:  1972-04-21       Impact factor: 49.962

3.  Sulphur-methylene isosterism in the development of metiamide, a new histamine H2-receptor antagonist.

Authors:  J W Black; G J Durant; J C Emmett; C R Ganellin
Journal:  Nature       Date:  1974-03-01       Impact factor: 49.962

4.  Metiamide--an orally active histamine H2-receptor antagonist.

Authors:  J W Black; W A Duncan; J C Emmett; C R Ganellin; T Hesselbo; M E Parsons; J H Wyllie
Journal:  Agents Actions       Date:  1973-10

5.  Proceedings: Effect of histamine H2-receptor antagonists on gastric secretion, circulation, and acid-base-balance in cats.

Authors:  M Albinus; K F Sewing
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1974       Impact factor: 3.000

6.  Does burimamide inhibit gastric acid secretion by a release of catecholamines?

Authors:  M Albinus; K F Sewing
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1973       Impact factor: 3.000

7.  Effect of burimamide on gastric acid secretion and gastric mucosal blood flow in cats.

Authors:  M Albinus; K F Sewing
Journal:  Agents Actions       Date:  1973-10
  7 in total
  4 in total

1.  Design, Synthesis, and Chemical and Biological Properties of Cyclic ADP-4-Thioribose as a Stable Equivalent of Cyclic ADP-Ribose.

Authors:  Takayoshi Tsuzuki; Satoshi Takano; Natsumi Sakaguchi; Takashi Kudoh; Takashi Murayama; Takashi Sakurai; Minako Hashii; Haruhiro Higashida; Karin Weber; Andreas H Guse; Tomoshi Kameda; Takatsugu Hirokawa; Yasuhiro Kumaki; Mitsuhiro Arisawa; Barry V L Potter; Satoshi Shuto
Journal:  Messenger (Los Angel)       Date:  2014-06-01

2.  Effects of the histamine H2-receptor blocking drugs burimamide and cimetidine on noradrenergic transmission in the isolated aorta of the rabbit and atria of the guinea-pig.

Authors:  M W McCulloch; I C Medgett; M J Rand
Journal:  Br J Pharmacol       Date:  1979-12       Impact factor: 8.739

3.  Inhibition of thromboxane A2 biosynthesis in human platelets by burimamide.

Authors:  G Allan; K E Eakins; P S Kulkarni; R Levi
Journal:  Br J Pharmacol       Date:  1980       Impact factor: 8.739

4.  Design and synthesis of cyclic ADP-4-thioribose as a stable equivalent of cyclic ADP-ribose, a calcium ion-mobilizing second messenger.

Authors:  Takayoshi Tsuzuki; Natsumi Sakaguchi; Takashi Kudoh; Satoshi Takano; Masato Uehara; Takashi Murayama; Takashi Sakurai; Minako Hashii; Haruhiro Higashida; Karin Weber; Andreas H Guse; Tomoshi Kameda; Takatsugu Hirokawa; Yasuhiro Kumaki; Barry V L Potter; Hayato Fukuda; Mitsuhiro Arisawa; Satoshi Shuto
Journal:  Angew Chem Int Ed Engl       Date:  2013-05-13       Impact factor: 15.336

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.